P2X7 receptor antagonism in the treatment of cancers

Bibliography

• Burnstock G. Purinergic nerves. Pharmacol Rev 1972;24(3):509-81
   PubMed Web of Science ®Google Scholar
• Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007;87(2):659-797
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signalling. Br J Pharmacol 2006;147(Suppl 1):S172-81
   PubMedGoogle Scholar
• Rassendren F, Buell GN, Virginio C, The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 1997;272(9):5482-6
   PubMed Web of Science ®Google Scholar
• North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;82(4):1013-67
   PubMed Web of Science ®Google Scholar
• Roger S, Pelegrin P, Surprenant A. Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J Neurosci 2008;28(25):6393-401
   PubMed Web of Science ®Google Scholar
• Roger S, Gillet L, Baroja-Mazo A, C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem 2010;285(23):17514-24
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. Embo J 2006;25(21):5071-82
   PubMed Web of Science ®Google Scholar
• Pelegrin P. Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1. Drug News Perspect 2008;21(8):424-33
   PubMed Web of Science ®Google Scholar
• Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 2007;28(9):465-72
   PubMed Web of Science ®Google Scholar
• Tam F, Unwin R, Arulkumaran N. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 2011;20(7):897-915
   Google Scholar
• Keystone EC, Wang MM, Layton M, Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis 2011. [Epub ahead of print]
   Google Scholar
• Wang X, Arcuino G, Takano T, P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004;10(8):821-7
   PubMed Web of Science ®Google Scholar
• Raffaghello L, Chiozzi P, Falzoni S, The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 2006;66(2):907-14
   PubMed Web of Science ®Google Scholar
• Pellegatti P, Raffaghello L, Bianchi G, Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 2008;3(7):e2599
   PubMedGoogle Scholar
• Mackenzie AB, Young MT, Adinolfi E, Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 2005;280(40):33968-76
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Chiozzi P, Falzoni S, Cytolytic P2X purinoceptors. Cell Death Differ 1998;5(3):191-9
   PubMed Web of Science ®Google Scholar
• Surprenant A, Rassendren F, Kawashima E, The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996;272(5262):735-8
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. Embo J 2009;28(14):2114-27
   PubMed Web of Science ®Google Scholar
• Adinolfi E, Melchiorri L, Falzoni S, P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002;99(2):706-8
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang L, Feng YH, P2X7 receptor-mediated apoptosis of human cervical epithelial cells. Am J Physiol Cell Physiol 2004;287(5):C1349-58
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Zheng GG, Ma XT, Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk Res 2004;28(12):1313-22
   PubMed Web of Science ®Google Scholar
• Slater M, Danieletto S, Pooley M, Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 2004;83(1):1-10
   PubMed Web of Science ®Google Scholar
• Slater M, Danieletto S, Gidley-Baird A, Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 2004;44(3):206-15
   PubMed Web of Science ®Google Scholar
• Deli T, Varga N, Adam A, Functional genomics of calcium channels in human melanoma cells. Int J Cancer 2007;121(1):55-65
   PubMed Web of Science ®Google Scholar
• Solini A, Cuccato S, Ferrari D, Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 2008;149(1):389-96
   PubMed Web of Science ®Google Scholar
• Slater M, Danieletto S, Barden JA. Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. J Mol Histol 2005;36(3):159-65
   PubMed Web of Science ®Google Scholar
• Wiley JS, Dao-Ung LP, Gu BJ, A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002;359(9312):1114-19
   PubMed Web of Science ®Google Scholar
• Feng YH, Li X, Wang L, A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 2006;281(25):17228-37
   PubMed Web of Science ®Google Scholar
• Feng YH, Li X, Zeng R, Endogenously expressed truncated P2X7 receptor lacking the c-terminus is preferentially upregulated in epithelial cancer cells and fails to mediate ligand-induced pore formation and apoptosis. Nucleosides Nucleotides Nucleic Acids 2006;25(9-11):1271-6
   PubMed Web of Science ®Google Scholar
• Li X, Zhou L, Feng YH, The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomarkers Prev 2006;15(10):1906-13
   PubMed Web of Science ®Google Scholar
• Zhou L, Luo L, Qi X, Regulation of P2X(7) gene transcription. Purinergic Signal 2009;5(3):409-26
   PubMed Web of Science ®Google Scholar
• Greig AV, Linge C, Healy V, Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 2003;121(2):315-27
   PubMed Web of Science ®Google Scholar
• White N, Butler PE, Burnstock G. Human melanomas express functional P2X(7) receptors. Cell Tissue Res 2005;321(3):411-18
   PubMed Web of Science ®Google Scholar
• White N, Knight GE, Butler PE, An in vivo model of melanoma: treatment with ATP. Purinergic Signal 2009;5(3):327-33
   PubMed Web of Science ®Google Scholar
• Rapaport E, Fishman RF, Gercel C. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res 1983;43(9):4402-6
   PubMed Web of Science ®Google Scholar
• Rapaport E. Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 1983;114(3):279-83
   PubMed Web of Science ®Google Scholar
• Rapaport E. Experimental cancer therapy in mice by adenine nucleotides. Eur J Cancer Clin Oncol 1988;24(9):1491-7
   PubMedGoogle Scholar
• Di Virgilio F, Ferrari D, Adinolfi E. P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal 2009;5(2):251-6
   PubMed Web of Science ®Google Scholar
• Ryu JK, Jantaratnotai N, Serrano-Perez MC, Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model. J Neuropathol Exp Neurol 2011;70(1):13-22
   PubMed Web of Science ®Google Scholar
• Jelassi B, Chantome A, Alcaraz-Perez F, P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 2011;30(18):2108-22
   Google Scholar
• Ren S, Zhang Y, Wang Y, Targeting P2X receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes. Cell Biol Int 2010;34(12):1205-11
   PubMed Web of Science ®Google Scholar
• Lopez-Castejon G, Theaker J, Pelegrin P, P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol 2010;185(4):2611-19
   PubMed Web of Science ®Google Scholar
• Gu BJ, Wiley JS. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 2006;107(12):4946-53
   PubMed Web of Science ®Google Scholar
• Ohshima Y, Tsukimoto M, Takenouchi T, Gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. Biochim Biophys Acta 2010;1800(1):40-6
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Apetoh L, Tesniere A, Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009;15(10):1170-8
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23(11):549-55
   PubMed Web of Science ®Google Scholar